|Outpatient Psychopharmacology Program|
The Psychosis Service has a dedicated outpatient psychopharmacology program. We use a recovery-oriented philosophy based on the Presidents New Freedom Commission report on transforming mental health care. Each patient's individual goals are reviewed within the context of the pharmacologic treatment. We are knowledgeable and experienced in the use of recently approved antipsychotic medications such as asenapine (Saphris), Iloperidone (Fanapt), and lurasidone (Latuda). We are currently conducting research studies on switching patients to either iloperidone (Fanapt) and lurasidone (Latuda). For those with persistent psychosis, we have a clozapine specialty program. For patients who have difficulty with having to contend with day-to-day medications, we have a program that gives long-acting injectable therapy between every 2 weeks to every 4 weeks.
Peter J. Weiden, M.D. and Hugo Solari, M.D., are Co-Directors of the psychopharmacology outpatient program, both of whom specialize in treatment of psychotic disorders. Doris Griffin, APN. is the Advanced Practice Nurse who also specialize in the treatment of psychotic disorders. Our consultant pharmacists are Jeffrey Bishop Pharm.D, BCPP and Shiyun Kim. Sharon Midcalf and Cherry Orsby are the administrative staff. The program sees patients every Monday afternoon. While each treatment is individualized, most patients are seen on a monthly basis. Patients are referred and seen by appointment only.